Related references
Note: Only part of the references are listed.Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
Trygve Holmoy et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
Carla Tortorella et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
Carla Tortorella et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
Clara Matute-Blanch et al.
BRAIN (2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Irene Hakansson et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
Vanessa Daccach Marques et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2018)
Neurofilaments and 10-year follow-up in multiple sclerosis
Alok Bhan et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Intercontinental validation of brain volume measurements using MSmetrix
Alessandro Finkelsztejn et al.
NEURORADIOLOGY JOURNAL (2018)
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
Laisheng Cai et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
J. Mellergard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
Lenka Novakova et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Correlation of clinical findings and brain volume data in multiple sclerosis
Yara Dadalti Fragoso et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Fluid biomarker and electrophysiological outcome measures for progressive MS trials
Christian Barro et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Fluid biomarker and electrophysiological outcome measures for progressive MS trials
Christian Barro et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Critical analysis on the present methods for brain volume measurements in multiple sclerosis
Yara Dadalti Fragoso et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Sahil Gupta et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Neurofilament light chain level is a weak risk factor for the development of MS
Georgina Arrambide et al.
NEUROLOGY (2016)
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Sahil Gupta et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice
C. Oreja-Guevara
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Assessing tissue damage in multiple sclerosis: a biomarker approach
J. Burman et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
Markus Axelsson et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
Lenka Fialova et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
Timucin Avsar et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'
Gavin Giovannoni
MULTIPLE SCLEROSIS JOURNAL (2010)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis - A monthly MRI study after triple-dose gadolinium-DTPA
A Paolillo et al.
JOURNAL OF NEUROLOGY (2004)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
Monoclonal antibodies selective for low molecular weight neurofilaments
N Norgren et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
C Bjartmar et al.
CURRENT OPINION IN NEUROLOGY (2001)
Share Paper
